Deprex

Quick links to important sections

Deprex

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Deprex

What is Deprex? A Concise Overview

To quickly establish the core identity of this medication, here are the essential details about Deprex.

Property Description
Active Ingredient Olanzapine (INN)
Form Oral Tablet
Pharmacological Class Atypical Antipsychotic (Second Generation)
Primary Therapeutic Goal Thought and Mood Stabilization
Origin Synthetic (Chemically Designed)

What Type of Medicine is Deprex?

Deprex is a prescription medicine containing the active ingredient olanzapine, and is classified as an Atypical Antipsychotic agent. This modern class of medication is used for its ability to help stabilize disturbed thought processes and severe emotional fluctuations.

The primary purpose of Deprex is to provide long-term therapeutic support for the central nervous system. Olanzapine achieves its stabilizing effect by influencing multiple chemical pathways in the brain, including those involving dopamine and serotonin, a key feature that differentiates it from older agents. This mechanism is intended to support the brain's capacity for stability and functional regulation over time.


Is Deprex a Targeted or Broad-Spectrum Agent?

Deprex is a synthetically manufactured, small-molecule drug known for its broad-spectrum affinity across various neuroreceptors. The medicine is not derived from natural sources, but is precisely compounded in a laboratory, ensuring a standardized, high-purity formulation for every dose.

The composition is distinct from both older single-target drugs and biological treatments. Typically provided as an oral tablet, its structure allows for a complex influence on the brain’s signaling systems. This capability is useful when managing conditions that involve both thought and mood components, helping to restore a baseline of emotional balance.

What side effects are possible with Deprex?

Possible Side Effects and Safety Information

The safety profile of Deprex (Olanzapine) is defined by common adverse reactions and the potential for serious, clinically significant events, as documented in regulatory sources.

Common and Very Common Adverse Reactions

The most frequently reported undesirable effects (Very Common, occurring in 10% or more of patients) are somnolence (sleepiness) and weight gain. Other common (1–10%) side effects include:

  • Metabolic changes: Increased appetite, elevated glucose levels, and elevated triglyceride/cholesterol levels.
  • Nervous System: Dizziness, akathisia (restlessness), asthenia (lack of energy), and mild anticholinergic effects like dry mouth and constipation.
  • Vascular/Other: Orthostatic hypotension (a drop in blood pressure upon standing), and peripheral edema.

Serious and Clinically Significant Safety Concerns

Official prescribing information highlights the need for caution regarding several serious conditions, which may require immediate discontinuation of treatment and clinical intervention. These include:

  • Neuroleptic Malignant Syndrome (NMS): A rare but potentially life-threatening reaction characterized by fever, severe muscle stiffness, altered mental status, and autonomic instability.
  • Tardive Dyskinesia: A disorder involving involuntary, repetitive movements, primarily of the face and tongue, which may be irreversible.
  • Blood Disorders: Cases of low leukocyte and/or neutrophil counts (leukopenia, neutropenia) have been reported, requiring regular monitoring of blood counts.
  • Seizures: Caution is advised in patients with a history of seizures or other factors that may lower the seizure threshold.

Population-Specific Restrictions and Monitoring

Deprex is contraindicated in patients with a known risk for narrow-angle glaucoma or a hypersensitivity to any of its components. Specific population-related safety notes include:

  • Elderly Patients (65 and over): A lower starting dose (5 mg/day) is recommended due to potential sensitivity.
  • Hepatic/Renal Impairment: A lower starting dose (5 mg/day) is recommended.
  • Pregnancy and Lactation: Use during pregnancy should occur only if the potential benefit justifies the potential risk to the fetus. Breastfeeding is not advised during treatment.

Overdose and Emergency Response

Deprex Overdose and When to Seek Help

A suspected Deprex overdose is a serious medical emergency that requires immediate medical attention. This guidance is based strictly on official regulatory documentation describing overdose manifestations and required emergency procedures.

Documented Overdose Manifestations

The official regulatory profile lists an array of symptoms resulting from overexposure. These commonly involve the Central Nervous System (CNS), presenting as a range from profound somnolence and agitation to coma and seizures. Other documented manifestations include tachycardia (fast heart rate), hypotension (low blood pressure), extrapyramidal symptoms, hyperpyrexia (high fever), and mydriasis (pupil dilation). Severe outcomes include respiratory depression and the potential for life-threatening cardiac arrhythmias due to QTc prolongation. Laboratory findings may note leukocytosis and elevated Creatine Phosphokinase (CPK) levels.

Required Emergency Actions

Seek immediate medical attention for any suspected overdosage. Management is symptomatic and supportive, as no specific antidote is known. Emergency procedures officially described include establishing and maintaining a patient's airway, ensuring adequate oxygenation and ventilation, and initiating continuous cardiovascular monitoring (ECG). Consideration may be given to activated charcoal administration. For treating hypotension, official labeling cautions against the use of epinephrine or dopamine. Overdoses in children may be associated with more significant adverse effects, requiring more active medical intervention.

Therapeutic Uses of Deprex

What Deprex Treats: Main Uses and Benefits

Deprex, containing olanzapine, is generally used across conditions presenting with acute episodes in two main therapeutic domains: schizophrenia and bipolar disorder. The medication is commonly used to manage the symptomatic manifestations associated with these key areas.


Stabilization of Thought and Mood Extremes

Deprex is considered relevant for managing symptom clusters that may become intense or disruptive, such as those of schizophrenia and the manic or mixed episodes of Bipolar I Disorder. It is used for managing symptoms that interfere with daily comfort. The medication supports patients during difficult episodes by easing distress associated with hallucinations, delusions, hyperactivity, and racing thoughts (symptoms related to heightened physiological activity). It is considered relevant in contexts involving heightened systemic burden, such as when used in combination with fluoxetine for treatment-resistant depression. This supportive relief may help patients cope more steadily with symptom fluctuations in situations where additional management of discomfort is required.


Quick Fact: Relief for Acute Agitation
Deprex is commonly used when short-term symptomatic assistance is needed to help with acute behavioral dyscontrol and severe psychomotor agitation.

Regulatory References

  1. NIH MedlinePlus overview of Olanzapine

Eligibility and Restrictions for Use

Official Eligibility Profile for Deprex (Olanzapine)

Official regulatory documentation defines the user population for Deprex by specific age restrictions and absolute exclusions.

Classification Eligibility Rule
Absolutely Contraindicated Elderly patients with dementia-related psychosis due to a documented increase in the risk of death, and patients with known hypersensitivity to olanzapine or its components.
Conditional Use / Caution Patients with moderate hepatic impairment, a history of seizures, or conditions sensitive to anticholinergic effects (e.g., narrow-angle glaucoma) must use the medicine with caution or under consideration of a lower starting dose.

Age-Related Eligibility

Deprex monotherapy is approved for adults and adolescents aged 13 and older. Combination use with fluoxetine is approved for children and adolescents aged 10 and older for Bipolar I depressive episodes. Safety and efficacy have not been established for children younger than these minimum age thresholds. Furthermore, use during the third trimester of pregnancy or while breastfeeding carries documented risks to the neonate and is only advised if the maternal benefit clearly justifies the potential risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Deprex (olanzapine) organizes its interactions into pharmacokinetic (PK), pharmacodynamic (PD), and substance interaction domains, based strictly on official regulatory documentation.

Pharmacokinetic and Exposure Interactions

These interactions alter Deprex plasma concentration through documented changes in clearance:

Interacting Agent Regulatory Outcome Statement
Carbamazepine Increased olanzapine clearance via enzyme induction, leading to reduced plasma concentrations.
Fluvoxamine, Ciprofloxacin, Ketoconazole Increased olanzapine plasma exposure due to reduced clearance/metabolism inhibition.
Tobacco Smoking Diminished plasma olanzapine concentrations due to CYP1A2 induction.

Pharmacodynamic and Substance Interactions

These interactions involve additive effects or functional antagonism documented in official labeling:

  • Centrally Acting Drugs: Co-administration with agents such as Diazepam carries a documented risk of additive effects, including potentiated orthostatic hypotension and increased drowsiness.
  • Antagonistic Agents: Deprex may antagonize the pharmacological effects of Levodopa and other Dopamine Agonists.
  • Antihypertensive Agents: An enhanced antihypertensive effect is officially noted when co-administered.
  • Alcohol: Use is documented to potentiate orthostatic hypotension and generally worsen depressant effects.

The overall interaction structure is defined by these documented changes in exposure and functional effect, which are classified as clinically significant and warrant specialized monitoring when co-administered.

Mechanism of Action

Deprex is a small molecule that acts as a selective allosteric modulator of the D2 receptor left( dopamine-2 ight). This selective interaction determines the drug’s primary pharmacodynamic action. The activation of the D2 receptor by Deprex initiates a sequence of intracellular events that results in the inhibition of adenylate cyclase activity within the cell. This enzymatic suppression consequently decreases the intracellular concentration of the second messenger cyclic adenosine monophosphate ( cAMP). This signal transduction event is primarily observed within specific neuronal populations of the nucleus accumbens.

Furthermore, Deprex modulates the AKT/GSK-3beta signaling pathway. By influencing the phosphorylation state of GSK-3beta, the drug alters downstream cellular processes. This biochemical activity affects neuronal plasticity in the prefrontal cortex and influences the release profile of inflammatory cytokines, contributing to broad physiological modulation of central nervous system pathways.

Dosage and Administration Information

How to Use Deprex: Official Administration Guidelines

Deprex (olanzapine) is administered through specific routes and schedules. The medicine is available for both oral and intramuscular (IM) administration; intravenous use is prohibited. Oral forms are utilized for routine management, while the short-acting IM solution is specifically indicated for acute agitation, and the long-acting IM form is used for maintenance.


Standard Dosing and Frequency

Established protocols define the following parameters based on the condition being addressed:

Indication/Route Starting Dose (Typical) Maximum Dose (Daily) Frequency
Schizophrenia (Oral) 10 mg once daily 20 mg Once Daily
Bipolar Mania (Oral) 10 mg or 15 mg once daily 20 mg Once Daily
Acute Agitation (IM) 10 mg (single dose) 30 mg As needed (with time intervals)

Procedural and Population Rules

Oral Deprex may be taken without regard to meals, as food does not impact its absorption. The oral dose is adjusted in increments, typically at intervals of not less than one week when treating schizophrenia, to allow the body time to stabilize the medicine. For specific patient populations, such as older adults or individuals with hepatic impairment, a lower starting dose (typically 5 mg/day) should be considered. When administering the short-acting intramuscular injection, the powder must be reconstituted with Sterile Water for Injection and used within one hour. Upon discontinuation of treatment, a gradual tapering of the dose is a common protocol. If a dose is missed, it should be taken as soon as remembered, unless it is close to the time for the next scheduled dose, and two doses should not be taken simultaneously.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Deprex (Olanzapine)


Evidence for Use in Schizophrenia Studies

The foundation of research for Deprex in schizophrenia is built upon short-term Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time, comparing the observed patterns in individuals taking Deprex against those receiving an inactive substance (placebo). Researchers focused on outcomes related to systemic or functional imbalance by measuring change in positive symptoms—such as hallucinations and delusions—and negative symptoms, which include social withdrawal and emotional blunting. Acute trials typically lasted four to six weeks. These studies reported measurements of symptom scale change in the observed populations, sometimes reporting observed differences in symptom scale change between the Deprex group and the placebo group. Following acute treatment, long-term observational settings and open-label extension studies were used to track patients over a year or more.

Evidence for Use in Bipolar I Disorder

Research has explored the use of Deprex for conditions associated with acute or disruptive episodes, specifically manic and mixed episodes of Bipolar I Disorder. The evidence includes short-term placebo-controlled RCTs applied in studies examining patient-reported experiences of acute changes. These trials typically monitored outcomes describing episodic or acute changes in adult patients. Studies focusing on episodes where symptoms become more noticeable reported measurements of scale change in manic symptom severity over three to six weeks. Research also monitored whether the continued use of the study drug was associated with differences in the rate of future episodes in long-term RCTs.

Research Gaps and What Remains Uncertain

The overall evidence landscape contributes to understanding symptom patterns, but some limitations exist. Long-term effects are not fully established by high-quality comparative evidence for all indications, as follow-up durations were limited in the most rigorous controlled trials. Comparative evidence against some newer therapeutic options remains lacking, as the research primarily compared Deprex to older treatments or placebo. Furthermore, data for certain groups remain insufficient, particularly for special populations not heavily represented in the initial large-scale studies. Findings were observed to vary when examining specific symptom subsets, and the reported changes in these areas are less consistent across the research base.

Key Studies & References

  1. NICE Guideline [CG178]: Psychosis and schizophrenia in adults: prevention and management
  2. NICE Guideline [CG185]: Bipolar disorder: assessment and management
  3. Olanzapine for Maintenance Treatment of Bipolar Disorder: A Systematic Review and Meta-Analysis

Frequently Asked Questions (FAQ)

Common questions about Deprex (FAQ)

Q: What is the main reason doctors prescribe Deprex?

A: Deprex is officially indicated for the treatment of schizophrenia and for the acute management and long-term maintenance of manic or mixed episodes associated with Bipolar I Disorder. These are the primary conditions for which the medication is approved by regulatory agencies. The medicine is intended to provide stability and support in managing these serious mental health conditions.


Q: How is Deprex different from other similar medications I've heard about?

A: The medicine is classified as an Atypical Antipsychotic, and official information describes its mechanism of action as influencing multiple brain chemicals. Specifically, it is noted to act by binding to both dopamine D2 and serotonin 5HT2 A receptors. This broad action helps to stabilize thought processes and emotional fluctuations.


Q: Why do some people need to take Deprex for a long time?

A: The medicine is approved for the maintenance treatment of certain conditions, which involves long-term management. This use is intended to provide stabilization and help prevent the recurrence of episodes over time. The goal is to sustain the therapeutic support achieved during acute treatment phases.


Q: What is the general safety classification of Deprex?

A: According to the official product information, Deprex is not classified as a controlled substance. This means it is not included in the schedules (I through V) maintained by the US Drug Enforcement Administration (DEA). This classification indicates the medicine is not subject to the regulatory controls concerning potential for abuse and dependency that are applied to scheduled medications.


Q: How quickly does Deprex usually start working?

A: The onset of effect can vary depending on the condition being addressed. For acute symptoms, initial effects may be seen within minutes (for the injection form) or days (for oral tablets used in acute mania). However, continued, full symptom improvement is usually observed gradually over the first 1 to 2 weeks of treatment.


Q: Can Deprex cause problems if I take common painkillers?

A: Regulatory sources advise caution when combining Deprex with certain prescription painkillers. Specifically, drugs such as morphine or tramadol may increase the sedative effects, leading to enhanced sleepiness or drowsiness. Official information notes the importance of ensuring a healthcare professional is aware of all medications being taken.


Q: Are there certain supplements that are commonly listed as interacting with Deprex?

A: Official health guidance notes that certain supplements, such as Cannabidiol (CBD), should be avoided while taking this medicine. Additionally, caution is generally advised with any herbal or dietary supplements known to cause drowsiness or dizziness.


Q: Does Deprex have a high risk of drug dependency?

A: The US Drug Enforcement Administration (DEA) has not classified Deprex as a controlled substance. This classification indicates the medicine is not subject to the regulatory controls concerning potential for abuse and dependency that are applied to scheduled medications.


Q: Is it true that Deprex can take several weeks to reach its full effect?

A: Yes, it is true that the time needed to reach the full therapeutic effect is often several weeks. Official information suggests that the full benefit of Deprex typically develops gradually over a period of 4 to 6 weeks. It is important to remember that progress can be gradual.


Q: Can Deprex be taken with common cold and flu medicines?

A: Caution is advised when taking common cold and flu medicines with Deprex. The medicine may enhance side effects like dizziness and drowsiness from cough suppressants like dextromethorphan. Furthermore, decongestants containing sympathomimetic agents should be used cautiously due to potential cardiovascular risks.


Q: Is Deprex a controlled substance?

A: No, according to the US Drug Enforcement Administration (DEA), Deprex is not classified as a controlled substance. This classification means it is not subject to the same regulatory controls concerning potential for abuse or dependency that are applied to scheduled medications.


Q: Does Deprex interact with birth control pills?

A: Yes, there is a documented interaction with a common component of oral contraceptives. Ethinyl estradiol, an ingredient in many birth control pills, may lead to increased blood levels of Deprex. This change in concentration could potentially cause an increase in expected side effects.


Q: Can men and women expect different side effects from Deprex?

A: Studies and official information indicate that differences in side effects between men and women may occur. For instance, women have shown a higher frequency of hyperprolactinemia (elevated prolactin levels). Men have shown a higher frequency of anticholinergic syndrome, which relates to side effects like dry mouth and constipation.


Q: What is the risk of accidental overdose with Deprex?

A: Overdose symptoms may include severe drowsiness, slurred speech, agitation, and uncontrollable movements. Official drug information also notes the potential for more severe outcomes, including coma. If an overdose is suspected, official guidance dictates that emergency medical attention must be sought immediately.


Q: Is Deprex safe to use before surgery?

A: Guidelines advise that the medication is generally continued before and during surgery, but caution is necessary. There is a documented risk that Deprex may increase the risk of hypotension (low blood pressure) when combined with certain anesthetics. Because of this documented risk, regulatory guidelines emphasize the necessity of the surgical team being informed of this medication.


Q: Can Deprex be crushed or split?

A: Regulatory guidance specifies that standard tablets are not intended to be crushed or split. For the orally disintegrating tablet (ODT) form, official guidance states that these should not be cut, crushed, or chewed, and must be administered according to specific handling instructions.


Q: Does Deprex interact with herbal supplements like St. John's Wort?

A: St. John’s Wort is specifically noted in regulatory summaries as an interacting supplement. Combining it with Deprex may increase the risk of side effects such as dizziness, drowsiness, and confusion. This highlights the importance of providing a comprehensive list of supplements to the prescribing professional.


Q: What does the patient leaflet mean by 'contraindications' for Deprex?

A: The term 'contraindication' refers to specific conditions or situations in which the medicine should not be used. Official documents list contraindications because using the drug in those circumstances could potentially be harmful to the patient. They are absolute restrictions listed for safety.


Q: Is there a generic version of Deprex available?

A: Yes, a generic version of the medicine is officially approved and available. The active ingredient, olanzapine, is manufactured by multiple companies. This is regulated by the FDA and other government authorities to ensure the generic formulation is therapeutically equivalent to the brand name.


Q: What should I do if I experience a potential interaction?

A: If a potential drug interaction is suspected, official guidance recommends seeking immediate assistance from a prescribing doctor or a healthcare professional. Official information documents the possibility of interactions that can affect how the medicine works or lead to increased side effects.


Q: Is Deprex considered a common type of medication for its purpose?

A: Yes, Deprex is considered a well-established medication within its therapeutic class. It is one of the available choices in the class of Atypical Antipsychotics used for its specific, approved indications. Its use is supported by regulatory clinical trial data.


Q: What should I generally expect the first week of using Deprex?

A: During the first week, you may begin to observe initial therapeutic effects, particularly for acute symptoms like agitation. It is also common for side effects such as sleepiness (somnolence) and dizziness to be reported early in treatment. These are noted in the official product information.


Q: Are the serious side effects of Deprex rare?

A: Official regulatory information indicates that serious safety concerns can arise, although some are noted as rare. Neuroleptic Malignant Syndrome (NMS), for example, is described as a rare but potentially life-threatening reaction. Serious events like Tardive Dyskinesia are highlighted in warnings as conditions that warrant clinical assessment.


Q: Does Deprex affect the ability to concentrate or drive?

A: Yes, the medicine has the potential to affect judgment, thinking, and motor skills due to common side effects like sleepiness. Official warnings advise using caution when operating machinery or driving. Regulatory documents emphasize that individuals should assess how the medicine affects them before engaging in activities that require full mental alertness.


Q: Can older adults generally use Deprex?

A: The use of Deprex in older adults is subject to specific regulatory precautions. Older individuals are typically started on a lower dose due to the potential for increased sensitivity. The medicine is absolutely contraindicated (must not be used) for elderly patients who have dementia-related psychosis.


Q: Are there any major diet restrictions when using Deprex?

A: According to official administration guidelines, there are no major restrictions regarding the types of food you eat. The medicine can be taken with or without food. The focus is generally on maintaining a stable nutritional status rather than avoiding specific foods.


Q: Is there a Black Box Warning associated with Deprex?

A: Yes, the official labeling for the medicine includes a Boxed Warning, sometimes called a Black Box Warning. This warning highlights the increased risk of death when the medicine is used to treat elderly patients who have conditions related to dementia-related psychosis. It is the most serious type of warning mandated by the FDA.


Q: Why do doctors recommend blood tests before starting Deprex?

A: Official guidelines recommend regular monitoring, which includes blood tests, both before starting and during treatment. This is necessary to check for potential blood cell count changes and to monitor for metabolic changes, such as elevated glucose and cholesterol levels, which can be associated with the medicine.


Q: Why is the medicine sometimes described as needing a 'washout' period?

A: The term 'washout' period refers to the need for a period of time without the medication before starting certain other treatments. This is sometimes necessary to ensure the medicine is fully cleared from the body, preventing potential drug-drug interactions or unintended effects when switching therapies.


Q: Is the research evidence for Deprex strong?

A: The official approval of Deprex is based on evidence derived from multiple short-term, placebo-controlled clinical trials. These trials demonstrated the medication's effectiveness in treating the conditions for which it is indicated. Research continues to contribute to understanding its effects over time.


Q: How does Deprex compare to older medications used for the same purpose?

A: Deprex is classified as an Atypical Antipsychotic, which distinguishes it from older, first-generation medications. Official information notes that the medicine affects a broader range of neuroreceptors, including both dopamine and serotonin receptors, which differentiates its mechanism of action.

How should Deprex be stored and disposed of?

How to Store and Dispose of Deprex (Olanzapine Oral Tablets)

Deprex must be stored according to regulatory requirements to ensure its stability and safety. The official conditions mandate storing the oral tablets at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The medication must be kept away from excess heat, moisture, and light.

The product should remain in its original container and be kept tightly closed. Storage must be out of the reach and sight of children, preferably in a secured location, as required by all regulatory agencies.

For disposal, unused or expired Deprex must be handled in accordance with local and national regulations, such as authorized drug take-back programs. The medicine should not be discarded into the sanitary sewer system or flushed down the toilet, to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Deprex found in:

A-Z Index: